Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advair HFA for HAPE Prevention and Exercise Performance
NCT06040268Phase 2Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Dec 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in high altitude pulmonary edema (HAPE) comparing Advair HFA with Placebo (2 arms). Primary endpoint: Maximal Oxygen Uptake at Day 3. Started Dec 2023; status: recruiting.
02
Drugs
salmeterol + fluticasone
03
Conditions
high altitude pulmonary edema (HAPE)
Beyond the preview
Go deeper on NCT06040268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06040268.